| Name | 4-[2-(3-cyclopentyloxy-4-methoxyphenyl)-2-phenylethyl]pyridine |
|---|
| Description | CDP-840 (GR259653X) is a potent, selective and orally active phosphodiesterase IV (PDE IV) inhibitor. CDP-840 inhibits antigen-induced early and late phase bronchoconstriction in conscious squirrel monkeys[1]. |
|---|---|
| Related Catalog | |
| Target |
PDE4 |
| References |
| Density | 1.122g/cm3 |
|---|---|
| Boiling Point | 489.9ºC at 760 mmHg |
| Molecular Formula | C25H27NO2 |
| Molecular Weight | 373.49 |
| Flash Point | 174.3ºC |
| Exact Mass | 373.20400 |
| PSA | 31.35000 |
| LogP | 5.78620 |
| Vapour Pressure | 2.88E-09mmHg at 25°C |
| Index of Refraction | 1.591 |
| Precursor 5 | |
|---|---|
| DownStream 0 | |